Hyperhomocysteinemia measured by immunoassay: A valid measure of coronary artery atherosclerosis

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 11, 2004, Pages 1263-1266

  Stauffenberg, Michele T ^a   Lange, Richard A ^a   Hillis, L David ^a   Cigarroa, Joaquin ^a   Hsu, Rebecca M ^a   Devaraj, Sridevi ^b   Jialal, Ishwarlal ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PLASMA; SEX ROLE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY STENOSIS; FASTING; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HOMOCYSTINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED;

EID: 7444242573     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Frishman WH. Biologic markers as predictors of cardiovascular disease. Am J Med. 1998;104:18S-27S.
2. Rader DJ. Inflammatory markers of coronary risk. N Engl J Med. 2000;343: 1179-1182.
3. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049-1057.
4. Yu HH, Joubran R, Asmi M, et al. Agreement among four homocysteine assays and results in patients with coronary atherosclerosis and controls. Clin Chem. 2000;46:258-264.
5. Marangon K, O'Byrne D, Devaraj S, Jialal I. Validation of an immunoassay for measurement of plasma total homocysteine. Am J Clin Pathol. 1999;112:757-762.
6. Lange RA, Hillis LD. Cardiac catheterization and hemodynamic assessment. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. Philadelphia, Pa: Lippincott-Raven; 1998:1957-1976.
7. Hundley WC, Hamilton CA, Clarke GD, et al. Visualization and functional assessment of proximal and middle left anterior descending coronary stenoses in humans with magnetic resonance imaging. Circulation. 1999;99:3248-3254.
8. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE, Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230-236.
9. Gerhard GT, Duell PB. Homocysteine and atherosclerosis. Curr Opin Lipidol. 1999;10:417-428.
10. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ. 1998;316:894-898.
11. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31-62.
12. Malinow MR, Duell PB, Hess DL, et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med. 1998;338:1009-1015.
13. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 2000; 102:2479-2483.